IMNM(Daily)Technical ChartImmunome Inc.
Formation: Double Bottom + Resisrance Line Breakout + RSI Divergence
Risk management: 1,5%
−1.86USD
−36.896MUSD
32.234M
About Immunome, Inc.
Sector
Industry
CEO
Clay B. Siegall
Website
Headquarters
Exton
Employees (FY)
37
Founded
2006
ISIN
US45257U1088
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Exton, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
